# TriRx Huntsville Pharmaceutical Services, LLC – FDA Inspection, Jun 15, 2026

Source: https://www.keypedia.com/records/fda_inspections/trirx-huntsville-pharmaceutical-services-llc/84548e82-46e0-4e70-b7ac-63ce50cfbc7f
Source feed: FDA_Inspections

> FDA inspection 1322326 of TriRx Huntsville Pharmaceutical Services, LLC, June 15, 2026. 5 citations under 21 CFR part 211. Form 483 issued. 13 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1322326
- Company Name: TriRx Huntsville Pharmaceutical Services, LLC
- Inspection Date: 2026-06-15
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: New Orleans District Office
- Citation Count: 5

## Related Documents

- [FDA Inspection 1216782 - 2023-08-11](https://www.keypedia.com/records/fda_inspections/trirx-huntsville-pharmaceutical-services-llc/3b33daf8-bfa6-437e-9d8f-1611b733a98f)
- FDA Inspection 1166895 - 2022-04-01
- FDA Inspection 978625 - 2016-04-21
- FDA Inspection 908381 - 2014-12-19
- FDA Inspection 891076 - 2014-08-01

## Related Officers

- [Investigator](https://www.keypedia.com/people/jeffrey-t-prosterman/1343bea3-692d-484e-b29f-c9f8f052f09c)

Company: https://www.keypedia.com/companies/trirx-huntsville-pharmaceutical-services-llc/bdf3220b-2a57-4125-b4ef-af4d1d9c9fa8

Office: https://www.keypedia.com/offices/new-orleans-district-office/95352142-b992-4e06-849d-d7483c0959ea